SUTRO BIOPHARMA, INC. (STRO) Weighted Average Number of Shares Outstanding, Diluted 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Sutro Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2024.
  • Sutro Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 61.5 M shares, a 4.66% increase year-over-year.
  • Sutro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 60.2 M shares, a 18.6% increase from 2022.
  • Sutro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 50.7 M shares, a 10% increase from 2021.
  • Sutro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 46.1 M shares, a 41.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 61.5 M +2.73 M +4.66% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 60.2 M +9.42 M +18.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 60.6 M +8.25 M +15.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 60.3 M +13.4 M +28.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 58.7 M +12.2 M +26.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 50.7 M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 52.3 M +6.18 M +13.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 47 M +841 K +1.82% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 46.5 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 46.2 M +8.28 M +21.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 46.1 M +14.3 M +45.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q3 2020 37.9 M +14.9 M +65.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 31.8 M +8.85 M +38.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q3 2019 22.9 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 22.9 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.